Healthcare

Federal Jury Convicts McKinney Ex-NFL Player Keith Gray in $328M Medicare Fraud

A federal jury in Dallas convicted 39-year-old McKinney resident Keith J. Gray on Feb. 20, 2026, for his role in a $328 million scheme to bill Medicare for medically unnecessary cardiovascular genetic tests.

Lisa Park2 min read
Published
Listen to this article0:00 min
Share this article:
Federal Jury Convicts McKinney Ex-NFL Player Keith Gray in $328M Medicare Fraud
AI-generated illustration

A federal jury in Dallas convicted Keith J. Gray, a 39-year-old McKinney resident and former college and NFL football player, for his role in a sprawling $328 million scheme to bill Medicare for medically unnecessary cardiovascular genetic tests. The verdict, reached on Feb. 20, 2026, marks a significant judgment against one of the largest alleged abuses tied to genetic testing and federal health benefits in recent years.

Prosecutors described the case as centered on cardiovascular genetic tests that were not medically necessary yet were submitted to Medicare for payment, producing the $328 million figure at the heart of the indictment. Those tests, billed through the scheme, targeted a federal program that covers many Collin County seniors and disabled residents, turning diagnostic tools into a vector for alleged fraud.

Gray’s conviction lands in McKinney, where neighbors had known him as a former college and NFL athlete turned business participant. The local dimension—Gray’s 39-year-old status as a Collin County resident—has amplified community concern about how a high-dollar billing scheme could touch people in this area who rely on Medicare for routine cardiovascular care and other services.

From a public health perspective, the case raises questions about the use and oversight of cardiovascular genetic testing. When tests that inform diagnosis or treatment are administered or billed without medical necessity, patients can face unnecessary follow-up procedures and anxiety, and the healthcare system bears avoidable costs. The $328 million figure underlines the scale at which unnecessary testing can drain federal resources intended for genuine medical need.

Beyond individual harm, the conviction spotlights policy and enforcement gaps that allowed large-scale billing of Medicare for genetic services. A federal jury in Dallas delivering a guilty verdict against Gray indicates heightened scrutiny of genetic testing companies and intermediaries that submit claims to Medicare. For Collin County health providers and administrators, the case underscores the need for tighter billing oversight and clearer clinical guidelines around cardiovascular genetic tests.

The verdict on Feb. 20, 2026, concludes the jury phase for Gray but leaves sentencing and any orders for restitution to the federal court. For Collin County residents watching the case, the outcome is a reminder that oversight of Medicare billing practices affects local healthcare access and the integrity of the benefits that many rely on for cardiac care.

Know something we missed? Have a correction or additional information?

Submit a Tip
Your Topic
Today's stories
Updated daily by AI

Name any topic. Get daily articles.

You pick the subject, AI does the rest.

Start Now - Free

Ready in 2 minutes

Discussion

More in Healthcare